Activity Overview
This educational activity is an archive of the live presentation held on February 21, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with melanoma and other cutaneous malignancies. Dermatologists, dermatopathologists, pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in treating melanoma and other cutaneous malignancies are invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Determine the role of biomarkers in developing personalized treatment plans for patients with skin cancers
- Assess recent evidence from clinical trials focusing on current and emerging novel treatment approaches for melanoma and other skin tumors
- Devise management protocols aligned with best practices for treating melanomas, squamous cell carcinoma, basal cell carcinoma, and other skin malignancies
- Develop strategies to identify and address complications in the treatment of skin cancers, including brain metastases and treatment-related toxicities
Omid Hamid, MD
Chief, Translational Research and Immunotherapy
Director, Melanoma Therapeutics
The Angeles Clinic and Research Institute, a Cedars-Sinai
Affiliate
Director, Cutaneous Malignancies, Cedars-Sinai Cancer
Director of Experimental Therapeutics, Cedars-Sinai
Los Angeles, CA
Sapna Patel, MD
Professor of Medicine and Ophthalmology
Dr William Robinson Endowed Chair in Cancer Research
University of Colorado | Anschutz Medical Campus
Aurora, CO
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.